“Boehringer has had a successful year as one of the leading research investors in the industry. Our impressive pipeline is coming together nicely, with many contributions from clinical trial sites in Australia and New Zealand," said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand. …
'We celebrate our 60th anniversary in Australia, I am extremely optimistic about the next 60'
April 17, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
Australia cannot afford complacency on life sciences, AusBiotech warns at 40
October 8, 2026 - - Latest News -
Life sciences sector warns that tax overhaul could push clinical trials offshore
October 8, 2026 - - Latest News -
Moderna and CSIRO launch five year biosecurity collaboration focused on Hendra vaccine
October 8, 2026 - - Latest News